Health Invest Partners Ab Autolus Therapeutics PLC Transaction History
Health Invest Partners Ab
- $208 Million
- Q4 2024
A detailed history of Health Invest Partners Ab transactions in Autolus Therapeutics PLC stock. As of the latest transaction made, Health Invest Partners Ab holds 479,644 shares of AUTL stock, worth $988,066. This represents 0.54% of its overall portfolio holdings.
Number of Shares
479,644
Previous 442,423
8.41%
Holding current value
$988,066
Previous $1.61 Million
29.78%
% of portfolio
0.54%
Previous 0.78%
Shares
4 transactions
Others Institutions Holding AUTL
# of Institutions
112Shares Held
156MCall Options Held
0Put Options Held
116K-
Wellington Management Group LLP Boston, MA25.3MShares$52.2 Million0.01% of portfolio
-
Blackstone Inc New York, NY20.5MShares$42.2 Million0.24% of portfolio
-
Syncona Portfolio LTD Guernsey, Channel Islands, X016.6MShares$34.3 Million73.83% of portfolio
-
Deep Track Capital, LP Greenwich, CT14.2MShares$29.3 Million1.47% of portfolio
-
Avoro Capital Advisors LLC New York, NY9.91MShares$20.4 Million0.34% of portfolio
About Autolus Therapeutics plc
- Ticker AUTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 90,909,800
- Market Cap $187M
- Description
- Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...